Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-020235

Head of Development sold 81 shares at $282.87 ($22,912)

  • Head of Development gave up 153 shares (to pay taxes)
  • Head of Development acquired 315 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Singhal Priya · Head of Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-30 Exercise or conversion : show line 1 in the form 10b5-1 +315 3,158.09 D
2023-06-30 Shares withheld for taxes : show line 2 in the form 10b5-1 −153 $284.85 $43,582 3,005.09 D
2023-07-03 Sale : show line 3 in the form 10b5-1 −81 $282.87 $22,912 2,924.09 D
Open-market sales · 81 sh · avg $282.87 · $22,912

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-30 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit −315 0 D
Loading xslF345X04/form4.xml…